119 related articles for article (PubMed ID: 38265260)
1. Incidence and survival for childhood cancer by endorsed non-stage prognostic indicators in Australia.
Youlden DR; Gupta S; Frazier AL; Moore AS; Gottardo NG; Aitken JF
Pediatr Blood Cancer; 2024 Apr; 71(4):e30889. PubMed ID: 38265260
[TBL] [Abstract][Full Text] [Related]
2. Incidence and survival for childhood central nervous system tumours in Australia, 1983-2016.
Youlden DR; Henshaw C; Gottardo NG; Hassall T; Aitken JF
J Neurooncol; 2021 Nov; 155(2):203-213. PubMed ID: 34664177
[TBL] [Abstract][Full Text] [Related]
3. Assessing the feasibility and validity of the Toronto Childhood Cancer Stage Guidelines: a population-based registry study.
Aitken JF; Youlden DR; Moore AS; Baade PD; Ward LJ; Thursfield VJ; Valery PC; Green AC; Gupta S; Frazier AL
Lancet Child Adolesc Health; 2018 Mar; 2(3):173-179. PubMed ID: 30169253
[TBL] [Abstract][Full Text] [Related]
4. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
[TBL] [Abstract][Full Text] [Related]
5. Italian cancer figures, report 2012: Cancer in children and adolescents.
; ;
Epidemiol Prev; 2013; 37(1 Suppl 1):1-225. PubMed ID: 23585445
[TBL] [Abstract][Full Text] [Related]
6. Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000-2017.
Youlden DR; Baade PD; Frazier AL; Gupta S; Gottardo NG; Moore AS; Aitken JF
Acta Oncol; 2023 Oct; 62(10):1256-1264. PubMed ID: 37647245
[TBL] [Abstract][Full Text] [Related]
7. Childhood cancer incidence in Australia, 1982-1991.
McWhirter WR; Dobson C; Ring I
Int J Cancer; 1996 Jan; 65(1):34-8. PubMed ID: 8543393
[TBL] [Abstract][Full Text] [Related]
8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
9. Temporal patterns in the risk of chronic health conditions in survivors of childhood cancer diagnosed 1970-99: a report from the Childhood Cancer Survivor Study cohort.
Gibson TM; Mostoufi-Moab S; Stratton KL; Leisenring WM; Barnea D; Chow EJ; Donaldson SS; Howell RM; Hudson MM; Mahajan A; Nathan PC; Ness KK; Sklar CA; Tonorezos ES; Weldon CB; Wells EM; Yasui Y; Armstrong GT; Robison LL; Oeffinger KC
Lancet Oncol; 2018 Dec; 19(12):1590-1601. PubMed ID: 30416076
[TBL] [Abstract][Full Text] [Related]
10. International benchmarking of childhood cancer survival by stage at diagnosis: The BENCHISTA project protocol.
Botta L; Gatta G; Didonè F; Lopez Cortes A; Pritchard-Jones K;
PLoS One; 2022; 17(11):e0276997. PubMed ID: 36327231
[TBL] [Abstract][Full Text] [Related]
11. Stage at diagnosis for childhood solid cancers in Australia: A population-based study.
Youlden DR; Frazier AL; Gupta S; Pritchard-Jones K; Kirby ML; Baade PD; Green AC; Valery PC; Aitken JF
Cancer Epidemiol; 2019 Apr; 59():208-214. PubMed ID: 30831553
[TBL] [Abstract][Full Text] [Related]
12. Stage at diagnosis and survival by stage for the leading childhood cancers in Rwanda.
Businge L; Hagenimana M; Motlhale M; Bardot A; Liu B; Anastos K; Castle PE; Murenzi G; Claire K; Sabushimike D; Cyuzuzo C; Kubwimana G; Maniragaba T; Uwinkindi F; Paczkowski M; Soerjomataram I; Parkin DM
Pediatr Blood Cancer; 2024 Jul; 71(7):e31020. PubMed ID: 38668553
[TBL] [Abstract][Full Text] [Related]
13. Childhood cancers in Chennai, India, 1990-2001: incidence and survival.
Swaminathan R; Rama R; Shanta V
Int J Cancer; 2008 Jun; 122(11):2607-11. PubMed ID: 18324630
[TBL] [Abstract][Full Text] [Related]
14. Renal tumours in Australian children: 30 years of incidence, outcome and second primary malignancy data from the Australian Childhood Cancer Registry.
Jones BC; Youlden DR; Cundy TP; O'Callaghan ME; Karpelowsky J; Aitken JF; McBride CA
J Paediatr Child Health; 2020 Jun; 56(6):908-916. PubMed ID: 31943452
[TBL] [Abstract][Full Text] [Related]
15. Stage at diagnosis for children with blood cancers in Australia: Application of the Toronto Paediatric Cancer Stage Guidelines in a population-based national childhood cancer registry.
Youlden DR; Gupta S; Frazier AL; Moore AS; Baade PD; Valery PC; Green AC; Aitken JF
Pediatr Blood Cancer; 2019 Jun; 66(6):e27683. PubMed ID: 30803139
[TBL] [Abstract][Full Text] [Related]
16. Childhood cancer.
Miller RW; Young JL; Novakovic B
Cancer; 1995 Jan; 75(1 Suppl):395-405. PubMed ID: 8001010
[TBL] [Abstract][Full Text] [Related]
17. Childhood cancer survival and avoided deaths in Australia, 1983-2016.
Youlden DR; Baade PD; Moore AS; Pole JD; Valery PC; Aitken JF
Paediatr Perinat Epidemiol; 2023 Jan; 37(1):81-91. PubMed ID: 35672573
[TBL] [Abstract][Full Text] [Related]
18. Incidence of childhood CNS tumours in Britain and variation in rates by definition of malignant behaviour: population-based study.
Stiller CA; Bayne AM; Chakrabarty A; Kenny T; Chumas P
BMC Cancer; 2019 Feb; 19(1):139. PubMed ID: 30744596
[TBL] [Abstract][Full Text] [Related]
19. The incidence of childhood cancer in Australia, 1983-2015, and projections to 2035.
Youlden DR; Baade PD; Green AC; Valery PC; Moore AS; Aitken JF
Med J Aust; 2020 Feb; 212(3):113-120. PubMed ID: 31876953
[TBL] [Abstract][Full Text] [Related]
20. Survival from childhood cancers in Eastern Africa: A population-based registry study.
Joko-Fru WY; Parkin DM; Borok M; Chokunonga E; Korir A; Nambooze S; Wabinga H; Liu B; Stefan C
Int J Cancer; 2018 Nov; 143(10):2409-2415. PubMed ID: 29981149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
